RepliCel to Present at the 4th Annual LD MICRO Growth Conference in Los Angeles, California
Luxe Sunset Bel Air Hotel, Los Angeles, California December 8th at 3:30 PM PDT
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 12/01/11 -- RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB: REPCF) is pleased to report that David Hall, CEO will be presenting at the LD MICRO Growth Conference on Thursday, December 8th at 3:30pm PDT. Mr. Hall's presentation will introduce RepliCel's autologous hair cell replication technology to over 150 institutions attending this two-day conference where some of the fastest growing companies on the OTC, NASDQ and NYSE are featured.
About LD MICRO
LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor.
About RepliCel Life Sciences
The Company has developed RepliCel™, a natural hair cell replication technology that has the potential to become the world's first, minimally invasive solution for androgenetic alopecia (pattern baldness) and general hair loss in men and women. RepliCel™ is based on autologous cell implantation technology that replicates a patient's hair cells from their own healthy hair follicles and, when reintroduced into areas of hair loss, the Company hopes to initiate natural hair regeneration. Patents for the technology have been issued by the European Union and Australia and are pending in other major international jurisdictions. The RepliCel™ procedure has been developed over the past nine years by the Company's recognized research scientists and medical experts - specialists in the fields of hair growth, hair biology and dermatology. Additional information about the Company is available at .
Contacts:
RepliCel Life Sciences Inc.
Tammey George
Director of Communications
604-248-8696
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 01.12.2011 - 18:30 Uhr
Sprache: Deutsch
News-ID 93242
Anzahl Zeichen: 0
contact information:
Town:
VANCOUVER, BRITISH COLUMBIA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 237 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"RepliCel to Present at the 4th Annual LD MICRO Growth Conference in Los Angeles, California"
steht unter der journalistisch-redaktionellen Verantwortung von
RepliCel Life Sciences Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
